One of Novo Nordisk's next-generation obesity shots to follow up on the success of Wegovy helped patients lose 22% of their ...

One of Novo Nordisk's next-generation obesity shots to follow up on its success with Wegovy helped patients lose 22% of their ...

Novo Nordisk today announced topline results from a phase 1b/2a clinical trial with amycretin, a unimolecular GLP-1 and amylin receptor agonist intended for once weekly ...

The company has so far only launched Wegovy in the U.S., Britain, Germany, Norway, and its home market Denmark. Wegovy is the first-to-market in a new class of highly effective weight-loss drugs.

European forces are seeking to beef up their military presence in Greenland just one week after President Donald Trump took ...

Denmark said on Monday it would spend 14.6 billion Danish kroner ($2.05 billion) boosting its military capabilities in the Arctic – a decision that comes amid continuing furor following US Presi ...

President Trump told Denmark’s leader he wanted to take over ... capitols and local government offices, leaving them at a loss on how to calculate its impact. Federal Work Force: The Trump ...

It came after Denmark said on Monday it plans to spend $2.05 billion to boost its military presence in the Arctic. While the Scandinavian country is responsible for Greenland's security and ...

COPENHAGEN, Jan 28 (Reuters) - Denmark's Prime Minister Mette Frederiksen said on Tuesday following a meeting with French President Emmanuel Macron that political leaders in Europe and beyond have ...

Novo Nordisk's U.S.-listed shares are surging 9% Friday morning after the Danish drugmaker reported early stage results for ...

Denmark has said it will spend 14.6 billion kroner (£1.6bn; $2.05bn) to boost security in the Arctic region, in partnership with its autonomous territories Greenland and the Faroe Islands.